Table 3.
The minimum non-pharmaceutical intervention(s), or minimum within-school vaccination coverage of the eligible population, needed to reduce the risk of symptomatic infection to beneath a given risk level (e.g., 50 cases per 1,000 population), assuming that 70% of the fall 2021 vaccine-eligible (12+) community has received a vaccine at 85% effectiveness. ‘Not observed’ indicates that no combination of interventions examined in this study reduced excess risk beneath the indicated threshold. Masks refers to universal masking regardless of vaccination status.
Population-wide risk tolerance — symptomatic cases per 1,000 population |
School-based risk tolerance — < 2 cases per school* | ||||
---|---|---|---|---|---|
<50 | <25 | <10 | |||
Students | Elementary school – half susceptibility | Masks | Masks + testing | Masks + cohorts | Masks + cohorts |
Elementary school – equal susceptibility | Masks + cohorts | Masks + cohorts | Not observed⁎⁎ | Not observed⁎⁎ | |
Middle school | Masks or 95% coverage | Masks + testing | Masks + cohorts | Not observed⁎⁎ | |
High school | Masks or 80% coverage | Masks | Masks + testing | Masks + cohorts | |
Teachers/staff | Elementary school – half susceptibility | Masks or 80% coverage | Masks + testing | Masks + cohorts | |
Elementary school – equal susceptibility | Masks + testing | Masks + cohorts | Not observed⁎⁎ | ||
Middle school | Masks or 90% coverage | Masks + testing | Masks + cohorts | ||
High school | Masks or 80% coverage | Masks or 95% coverage | Masks + testing |
Assuming a 380-person elementary school, 420-person middle school, and 680-person high school.
Not observed under the interventions examined here.